nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Tolcapone—Infestation—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Tolcapone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Tolcapone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Tolcapone—Discomfort—Triamcinolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Tolcapone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Tolcapone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Tolcapone—Stomatitis—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Tolcapone—Angiopathy—Prednisone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Tolcapone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Tolcapone—Malaise—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Malaise—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Oedema—Triamcinolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Vertigo—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Vertigo—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Syncope—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Syncope—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Tolcapone—Arrhythmia—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Tolcapone—Infection—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Tolcapone—Sweating—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Tolcapone—Infection—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Tolcapone—Haematuria—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Tolcapone—Shock—Triamcinolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Tolcapone—Alopecia—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Tolcapone—Shock—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Tolcapone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Tolcapone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Mental disorder—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Tolcapone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Tolcapone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Tolcapone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Tolcapone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Tolcapone—Hypertension—Betamethasone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Tolcapone—Myalgia—Betamethasone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Tolcapone—Myalgia—Dexamethasone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Tolcapone—Anxiety—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Tolcapone—Anxiety—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Tolcapone—Discomfort—Betamethasone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Tolcapone—Discomfort—Dexamethasone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Tolcapone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Tolcapone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Tolcapone—Pain—Prednisolone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Tolcapone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Tolcapone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Tolcapone—Vision blurred—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Tolcapone—Oedema—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Tolcapone—Oedema—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Tolcapone—Infection—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Tolcapone—Infection—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Tolcapone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Tolcapone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Tolcapone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Tolcapone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Tolcapone—Anaemia—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Shock—Betamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Shock—Dexamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Agitation—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Tolcapone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Tolcapone—Tachycardia—Betamethasone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Tolcapone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Tolcapone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Tolcapone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Tolcapone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Tolcapone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Tolcapone—Malaise—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Tolcapone—Vertigo—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Syncope—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Anorexia—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Anorexia—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Urticaria—Prednisolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Tolcapone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Tolcapone—Pain—Triamcinolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Tolcapone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Tolcapone—Hypotension—Betamethasone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Tolcapone—Hypotension—Dexamethasone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Tolcapone—Hypertension—Prednisone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Tolcapone—Chills—Methotrexate—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000993	0.000993	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000993	0.000993	CcSEcCtD
Tolcapone—Arthralgia—Prednisone—ankylosing spondylitis	0.00099	0.00099	CcSEcCtD
Tolcapone—Myalgia—Prednisone—ankylosing spondylitis	0.00099	0.00099	CcSEcCtD
Tolcapone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00099	0.00099	CcSEcCtD
Tolcapone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000987	0.000987	CcSEcCtD
Tolcapone—Anxiety—Prednisone—ankylosing spondylitis	0.000986	0.000986	CcSEcCtD
Tolcapone—Alopecia—Methotrexate—ankylosing spondylitis	0.000986	0.000986	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000983	0.000983	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00098	0.00098	CcSEcCtD
Tolcapone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000978	0.000978	CcSEcCtD
Tolcapone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000978	0.000978	CcSEcCtD
Tolcapone—Discomfort—Prednisone—ankylosing spondylitis	0.000978	0.000978	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000978	0.000978	CcSEcCtD
Tolcapone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000962	0.000962	CcSEcCtD
Tolcapone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000959	0.000959	CcSEcCtD
Tolcapone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000959	0.000959	CcSEcCtD
Tolcapone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000954	0.000954	CcSEcCtD
Tolcapone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000952	0.000952	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000952	0.000952	CcSEcCtD
Tolcapone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000949	0.000949	CcSEcCtD
Tolcapone—Oedema—Prednisone—ankylosing spondylitis	0.000949	0.000949	CcSEcCtD
Tolcapone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Tolcapone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Tolcapone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Tolcapone—Infection—Prednisone—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000941	0.000941	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000941	0.000941	CcSEcCtD
Tolcapone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000939	0.000939	CcSEcCtD
Tolcapone—Fatigue—Betamethasone—ankylosing spondylitis	0.000939	0.000939	CcSEcCtD
Tolcapone—Shock—Prednisone—ankylosing spondylitis	0.000934	0.000934	CcSEcCtD
Tolcapone—Pain—Dexamethasone—ankylosing spondylitis	0.000932	0.000932	CcSEcCtD
Tolcapone—Pain—Betamethasone—ankylosing spondylitis	0.000932	0.000932	CcSEcCtD
Tolcapone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000931	0.000931	CcSEcCtD
Tolcapone—Tachycardia—Prednisone—ankylosing spondylitis	0.000926	0.000926	CcSEcCtD
Tolcapone—Skin disorder—Prednisone—ankylosing spondylitis	0.000922	0.000922	CcSEcCtD
Tolcapone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000917	0.000917	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000916	0.000916	CcSEcCtD
Tolcapone—Anorexia—Prednisone—ankylosing spondylitis	0.000905	0.000905	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000902	0.000902	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—ankylosing spondylitis	0.000898	0.000898	CcSEcCtD
Tolcapone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000898	0.000898	CcSEcCtD
Tolcapone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000898	0.000898	CcSEcCtD
Tolcapone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000891	0.000891	CcSEcCtD
Tolcapone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000891	0.000891	CcSEcCtD
Tolcapone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000885	0.000885	CcSEcCtD
Tolcapone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000883	0.000883	CcSEcCtD
Tolcapone—Malaise—Methotrexate—ankylosing spondylitis	0.000876	0.000876	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—ankylosing spondylitis	0.000873	0.000873	CcSEcCtD
Tolcapone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
Tolcapone—Urticaria—Betamethasone—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000865	0.000865	CcSEcCtD
Tolcapone—Dizziness—Prednisolone—ankylosing spondylitis	0.000864	0.000864	CcSEcCtD
Tolcapone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000862	0.000862	CcSEcCtD
Tolcapone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000861	0.000861	CcSEcCtD
Tolcapone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000861	0.000861	CcSEcCtD
Tolcapone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000861	0.000861	CcSEcCtD
Tolcapone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000861	0.000861	CcSEcCtD
Tolcapone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00086	0.00086	CcSEcCtD
Tolcapone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000852	0.000852	CcSEcCtD
Tolcapone—Pruritus—Triamcinolone—ankylosing spondylitis	0.00085	0.00085	CcSEcCtD
Tolcapone—Cough—Methotrexate—ankylosing spondylitis	0.000848	0.000848	CcSEcCtD
Tolcapone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000848	0.000848	CcSEcCtD
Tolcapone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000835	0.000835	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—ankylosing spondylitis	0.000827	0.000827	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000827	0.000827	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—ankylosing spondylitis	0.000827	0.000827	CcSEcCtD
Tolcapone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000825	0.000825	CcSEcCtD
Tolcapone—Rash—Prednisolone—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Tolcapone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000822	0.000822	CcSEcCtD
Tolcapone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00082	0.00082	CcSEcCtD
Tolcapone—Fatigue—Prednisone—ankylosing spondylitis	0.000818	0.000818	CcSEcCtD
Tolcapone—Headache—Prednisolone—ankylosing spondylitis	0.000818	0.000818	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—ankylosing spondylitis	0.000817	0.000817	CcSEcCtD
Tolcapone—Constipation—Prednisone—ankylosing spondylitis	0.000811	0.000811	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—ankylosing spondylitis	0.0008	0.0008	CcSEcCtD
Tolcapone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000794	0.000794	CcSEcCtD
Tolcapone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000792	0.000792	CcSEcCtD
Tolcapone—Infection—Methotrexate—ankylosing spondylitis	0.000788	0.000788	CcSEcCtD
Tolcapone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000782	0.000782	CcSEcCtD
Tolcapone—Asthenia—Betamethasone—ankylosing spondylitis	0.000782	0.000782	CcSEcCtD
Tolcapone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000782	0.000782	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000778	0.000778	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000776	0.000776	CcSEcCtD
Tolcapone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000776	0.000776	CcSEcCtD
Tolcapone—Nausea—Prednisolone—ankylosing spondylitis	0.000776	0.000776	CcSEcCtD
Tolcapone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000771	0.000771	CcSEcCtD
Tolcapone—Pruritus—Betamethasone—ankylosing spondylitis	0.000771	0.000771	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—ankylosing spondylitis	0.00077	0.00077	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000767	0.000767	CcSEcCtD
Tolcapone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000764	0.000764	CcSEcCtD
Tolcapone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000762	0.000762	CcSEcCtD
Tolcapone—Rash—Triamcinolone—ankylosing spondylitis	0.000757	0.000757	CcSEcCtD
Tolcapone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Tolcapone—Rash—Methylprednisolone—ankylosing spondylitis	0.000755	0.000755	CcSEcCtD
Tolcapone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000755	0.000755	CcSEcCtD
Tolcapone—Urticaria—Prednisone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Tolcapone—Headache—Triamcinolone—ankylosing spondylitis	0.000752	0.000752	CcSEcCtD
Tolcapone—Headache—Methylprednisolone—ankylosing spondylitis	0.000751	0.000751	CcSEcCtD
Tolcapone—Body temperature increased—Prednisone—ankylosing spondylitis	0.00075	0.00075	CcSEcCtD
Tolcapone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00075	0.00075	CcSEcCtD
Tolcapone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000746	0.000746	CcSEcCtD
Tolcapone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000746	0.000746	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—ankylosing spondylitis	0.000741	0.000741	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000723	0.000723	CcSEcCtD
Tolcapone—Dizziness—Betamethasone—ankylosing spondylitis	0.000721	0.000721	CcSEcCtD
Tolcapone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000721	0.000721	CcSEcCtD
Tolcapone—Nausea—Triamcinolone—ankylosing spondylitis	0.000713	0.000713	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000712	0.000712	CcSEcCtD
Tolcapone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000712	0.000712	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000707	0.000707	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—ankylosing spondylitis	0.000705	0.000705	CcSEcCtD
Tolcapone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000699	0.000699	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000698	0.000698	CcSEcCtD
Tolcapone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000693	0.000693	CcSEcCtD
Tolcapone—Vomiting—Betamethasone—ankylosing spondylitis	0.000693	0.000693	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000689	0.000689	CcSEcCtD
Tolcapone—Rash—Dexamethasone—ankylosing spondylitis	0.000687	0.000687	CcSEcCtD
Tolcapone—Rash—Betamethasone—ankylosing spondylitis	0.000687	0.000687	CcSEcCtD
Tolcapone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000686	0.000686	CcSEcCtD
Tolcapone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000686	0.000686	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000685	0.000685	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Tolcapone—Headache—Dexamethasone—ankylosing spondylitis	0.000683	0.000683	CcSEcCtD
Tolcapone—Headache—Betamethasone—ankylosing spondylitis	0.000683	0.000683	CcSEcCtD
Tolcapone—Asthenia—Prednisone—ankylosing spondylitis	0.000681	0.000681	CcSEcCtD
Tolcapone—Pain—Methotrexate—ankylosing spondylitis	0.000678	0.000678	CcSEcCtD
Tolcapone—Pruritus—Prednisone—ankylosing spondylitis	0.000671	0.000671	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000654	0.000654	CcSEcCtD
Tolcapone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000649	0.000649	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000648	0.000648	CcSEcCtD
Tolcapone—Nausea—Dexamethasone—ankylosing spondylitis	0.000647	0.000647	CcSEcCtD
Tolcapone—Nausea—Betamethasone—ankylosing spondylitis	0.000647	0.000647	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—ankylosing spondylitis	0.00063	0.00063	CcSEcCtD
Tolcapone—Dizziness—Prednisone—ankylosing spondylitis	0.000628	0.000628	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000627	0.000627	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000627	0.000627	CcSEcCtD
Tolcapone—Vomiting—Prednisone—ankylosing spondylitis	0.000603	0.000603	CcSEcCtD
Tolcapone—Rash—Prednisone—ankylosing spondylitis	0.000598	0.000598	CcSEcCtD
Tolcapone—Dermatitis—Prednisone—ankylosing spondylitis	0.000598	0.000598	CcSEcCtD
Tolcapone—Headache—Prednisone—ankylosing spondylitis	0.000594	0.000594	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000584	0.000584	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—ankylosing spondylitis	0.000569	0.000569	CcSEcCtD
Tolcapone—Nausea—Prednisone—ankylosing spondylitis	0.000564	0.000564	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—ankylosing spondylitis	0.000561	0.000561	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000543	0.000543	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—ankylosing spondylitis	0.000524	0.000524	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—ankylosing spondylitis	0.000504	0.000504	CcSEcCtD
Tolcapone—Rash—Methotrexate—ankylosing spondylitis	0.0005	0.0005	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—ankylosing spondylitis	0.0005	0.0005	CcSEcCtD
Tolcapone—Headache—Methotrexate—ankylosing spondylitis	0.000497	0.000497	CcSEcCtD
Tolcapone—Nausea—Methotrexate—ankylosing spondylitis	0.000471	0.000471	CcSEcCtD
